Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display session

204P - Liver transplantation vs liver resection among hepatocellular carcinoma patients with or without prior malignancies

Date

27 Jun 2024

Session

Poster Display session

Presenters

Maha Jaradat

Citation

Annals of Oncology (2024) 35 (suppl_1): S75-S93. 10.1016/annonc/annonc1478

Authors

M. Jaradat, M.M. Hamad

Author affiliations

  • IAU - The University of Jordan, Amman/JO

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 204P

Background

Hepatocellular carcinoma (HCC) is considered a cancer with high mortality rates. Different treatment modalities have been used for it, including surgical resection and transplantation. Although treatment decision for HCC is multifactorial, suitable candidates often undergo surgery, whether it is liver resection or liver transplantation, however, which one is better is controversial. This study aimed to look at the effect of having prior malignancy on survival outcomes between the two surgeries.

Methods

The SEER database was used to identify patients diagnosed with hepatocellular carcinoma between 2000 and 2020, and then they were classified according to the kind of surgeries they had, whether it was a partial hepatectomy or liver transplantation. Kaplan-Meier curves and the log-rank test were used for survival analysis, which was conducted by SPPS v.27.

Results

10058 patients with HCC were included in this study, of which 1455 (14.5%) had a history of prior cancer. Among those who had a liver resection, there was a significant difference in 5-year age-standardized relative survival among patients with or without a prior history of cancer (p<0.001) with 49.9%, and 55.2%, respectively. However, no differences were observed for patients who underwent liver transplantation (p=0.272, with prior cancer 73.5%, without prior cancer 80.2%).

Conclusions

Although some studies suggested that the presence of prior cancer doesn't significantly contribute to worse outcomes, our findings revealed that primary HCC has a better survival outcome than subsequent HCC for patients who underwent partial hepatectomy. Regardless of prior cancer history, liver transplantation appears to offer consistent survival benefits for patients with HCC, which warrants further investigation. To optimize outcomes in HCC management, treatment approaches should be individualized based on patients' medical histories and prognostic factors.

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.